Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15109 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Xinli Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical Col…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Inflammation, Myocardium, Ventricular Remodeling. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National High Level Hospital Clinical Research Funding of China, National High Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Aims
Chronic low-grade inflammation, often observed in hypertrophic cardiomyopathy (HCM), promotes adverse ventricular remodelling. This study aimed to investigate the relationship between inflammatory markers and myocardial fibrosis (MF) in patients with HCM. Methods and results This study included 102 patients with complete baseline data who underwent septal myectomy. Myocardial samples were stained with Masson’s trichrome and analysed to determine myocardial collagen content and MF levels. Plasma levels of inflammatory markers were measured using standard laboratory procedures. Univariate and multivariate logistic regression analyses were performed to explore the relationship between the inflammatory markers and MF. Among the 102 participants included in the analysis, the mean age was 48.9 years, with 69 [67.6%] being men. The overall MF ranged from 2.5% to 40.7% (mean = 15.2 ± 8.1%, median = 13.0%, IQR = 9.9%–18.4%). Participants were divided into two groups based on a median MF of 13%. The high MF group had a larger left atrial diameter and left ventricular ejection fraction. Levels of interleukin (IL)-2, tumour necrosis factor (TNF)-α and interferon (IFN)-α were significantly higher in patients with high MF compared to those with low MF (2.3 vs. 4.0 pg/mL, 3.1 vs. 3.9 pg/mL, 4.2 vs.4.7 pg/mL, respectively; all P < 0.05). In multivariate models adjusted for age, sex and other clinical features, IL-2, IL-5 and TNF-α, were correlated with increased interstitial MF [odds ratio (OR): 1.54, 95% confidence interval (CI): 1.10–2.14; OR: 1.42, 95% CI: 1.02–1.98; OR: 1.33, 95% CI: 1.04–1.70]. After additional adjustment for imaging indicators, IL-2 and TNF-α remained significant (OR: 1.49, 95% CI: 1.06–2.09, P = 0.021; OR:1.35, 95% CI: 1.01–1.80, P = 0.044). The correlation analysis between inflammation and replacement fibrosis assessed by CMR in 97 patients revealed that 72 (74.2%) showed late gadolinium enhancement (LGE). No significant correlation was found between inflammatory markers and the presence or extent of LGE.
Conclusions
Higher levels of IL-2 and TNF-α were associated with increased histopathological interstitial MF in patients with HCM. Given the gradual progression of MF in HCM, initiating anti-inflammatory treatment in the early stages may delay its progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
- Department of Geriatrics, Peking University First Hospital, Beijing, China.
- Department of Heart failure, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
- Department of Cardiovascular surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China.
Förderung
- National High Level Hospital Clinical Research Funding of China
- National High Level Hospital Clinical Research Funding
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Guo, X., Zhang, J., Huang, M., Song, C., Nie, C., Zheng, X., Wang, S., & Huang, X. (2025). Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.15109
Vancouver
Guo X, Zhang J, Huang M, Song C, Nie C, Zheng X, et al. Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy. ESC Heart Failure. 2025. doi:10.1002/ehf2.15109
BibTeX
@article{Guo2025,
author = {Guo, Xinli and Zhang, Jian and Huang, Manyun and Song, Changpeng and Nie, Changrong and Zheng, Xinxin and Wang, Shuiyun and Huang, Xiaohong},
title = {Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15109}
}
EUVIMED